Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. A mechanism for losing excess cholesterol esters.

The abbreviations used are: VLDL, plasma very low density lipoproteins; IDL, plasma intermediate density lipoproteins; LDL, plasma low density lipoproteins, HDL, plasma high density lipoproteins; "LDL", in uitro-produced low density lipoprotein-like particles; M-VLDL, M-LDL, M-"LDL", etc., lipoproteins modified after incubations with VLDL; Mp-LDL, postlipolysis M-LDL after incubation with lipoprotein lipase;